Story · Medicine & Biotech

Study: Nirsevimab, Abrysvo provide similar protection against RSV

1 outlet · first reported by Healio 6d ago

Coverage, in order

  1. 6d ago
    Healio indie study
    Study: Nirsevimab, Abrysvo provide similar protection against RSV

    WASHINGTON — Nirsevimab and maternal vaccination offered similar levels of protection against respiratory syncytial virus among newborns, according to recently published data. Previous studies have shown that nirsevimab (Beyfortus, AstraZeneca/Sanofi) and the maternal vaccine (Abrysvo, Pfizer)…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.